Form 3 Filing for ENDRA Life Sciences Inc.

This SEC filing (Form 3) details the initial ownership of securities by ASP Isotopes Inc. and its subsidiary LHE LNG Holdings LLC in ENDRA Life Sciences Inc. (NDRA). ASP Isotopes Inc. and LHE LNG Holdings LLC are identified as ten percent owners. The filing reports 66,846 shares of common stock held by LHE LNG. Additionally, it discloses holdings of pre-funded warrants for up to 511,541 shares of common stock and warrants for up to 1,156,774 shares of common stock. The pre-funded warrants are exercisable within 60 days or upon stockholder approval, while the regular warrants require stockholder approval for exercise and expire on May 27, 2031. The exercise price for the regular warrants is $6.57.